In contrast, we found there was a trend for lower Megf6 expression being predictive of poorer B-cell lymphoma outcome (e.g., Xiao – 420, fRMA-u133p2 dataset; P = 0.061) (Fig. 2d). The gene discussed is MEGF6; the disease is B-cell non-Hodgkin lymphoma.